RB

Rameshwar Babasaheb Agale

Active Director Director DIN 11073619
DIN 11073619 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rameshwar Babasaheb Agale

Data last updated:

Rameshwar Babasaheb Agale is a Director at Ved Medisales Private Limited (since 2025).

DIN 11073619
Primary Designation Director
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ved Medisales Private Limited U46497MH2025PTC446629
Director24 Apr 20252025Active

Board colleagues of Rameshwar Babasaheb Agale

Directorship timeline

Open interactive timeline →
Ved Medisales Private Limited
Premium access

Shareholding and investment profile for Rameshwar Babasaheb Agale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rameshwar Babasaheb Agale

Rameshwar Babasaheb Agale currently holds 1 directorship: Ved Medisales Private Limited (Director, since 24 Apr 2025).

Rameshwar Babasaheb Agale was first appointed on 24 Apr 2025 as Director at Ved Medisales Private Limited.

The current boards of Rameshwar Babasaheb Agale's companies include Bhalchandra Narayanrao Waloorkar (Ved Medisales Private Limited), Khole Shekhar Gaurishankar (Ved Medisales Private Limited), Santosh Gaurishankar Khole (Ved Medisales Private Limited), Sunil Gaurishankar Khole (Ved Medisales Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available